UROV Crosses Above Average Analyst Target
January 22, 2021 at 08:03 AM EST
In recent trading, shares of Urovant Sciences Ltd (UROV) have crossed above the average analyst 12-month target price of $16.17, changing hands for $16.19/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..